Comparison between seronegative rheumatoid arthritis and polyarticular psoriatic arthritis: cross-sectional study in a Brazilian cohort
Abstract
Objectives: the study compared seronegative RA and polyarticular psoriatic arthritis (APs) in terms of cardiovascular risk, quality of life, depression, and functionality. Materials and methods: data from 45 patients with seronegative RA and 36 with polyarticular APs were analyzed. Questionnaires were used to assess depression (CES-D), functionality (Health Assessment Questionnaire-HAQ), and quality of life (SF-12). Carotid intima-media thickness (cIMT) was measured to assess cardiovascular risk. Results: the results showed similar rates of hypertension, diabetes, and dyslipidemia between both groups. However, patients with APs had higher BMI and abdominal circumference. cIMT was equivalent between groups. Depression and quality of life did not show significant differences. Patients with RA presented worse functionality, according to the HAQ. Conclusions: in our cohort, patients with RA and seronegative APs had similarities in quality of life, depression, and cardiovascular risk, except for differences in BMI and abdominal circumference, which were higher in APs. Functionality was worse in AR compared to APs.References
I. Grellmann C, Dombrowsky W, Fabricius V, Suruki R, Sheahan A, Joeres L. Epidemiology, and treatment of patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis in Germany: A real-world evidence study. Adv Ther 2021;38(1):366-385. doi: 10.1007/s12325-020-01522-8.
II. Merola JF, Espinoza LR, Fleischmann R. Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open 2018; 4(2): e000656. doi: 10.1136/rmdopen-2018-000656. eCollection 2018.
III. Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, et al. Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis. 2020; 12:1759720X20976975. doi: 10.1177/1759720X20976975.
IV. González-Martin C, Grande Morais S, Pertega-Diaz S, Seoane-Pillado T, Balboa-Barreiro V, Veiga-Seijo R. Concordance between the different cardiovascular risk scores in people with rheumatoid arthritis and psoriasis arthritis. Cardiol Res Pract 2019; 2019:7689208. doi: 10.1155/2019/7689208. eCollection 2019.
V. Labitigan M, Bahče-Altuntas A, Kremer JM, Reed G, Greenberg JD, Jordan N, et al. Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014; 66(4):600-7. doi: 10.1002/acr.22185.
VI. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2010; 37(12):2566-72. doi: 10.3899/jrheum.100483.
VII. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81. doi: 10.1002/art.27584.
VIII. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54(8): 2665-73. doi: 10.1002/art.21972.
IX. Silveira DJ; Jorge MR. Psychometric properties of the Epidemiologic Screening Scale for Depression (CES-D) in clinical and non-clinical populations of adolescents and young adults. Rev Psiquiatr Clin (São Paulo) 1998; 25(5):251-61. doi: 10.1590/1516-4446-2012-0875.
X. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P. Crosscultural reliability of the physical ability dimension of the health assessment questionnaire. J Rheumatol 1990; 17(6):813-7. PMID: 2388204.
XI. Andrade TL, Camelier AA, Rosa FW, Santos MP, Jezler S, Pereira e Silva JL. Applicability of the 12-Item Short-Form Health Survey in patients with progressive systemic sclerosis. J Bras Pneumol 2007; 33:414-22. doi: 10.1590/s1806-37132007000400010.
XII. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, et al. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011). An update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011 Cerebrovasc Dis 2012; 34:290–6. doi: 10.1159/000343145.
XIII. Toborek M, Kaiser S. Endothelial cell function: relationship to atherogenesis. Basic Res Cardiol 1999;94:295-314. doi: 10.1007/s003950050156.
XIV. Kubrusly M, Oliveira CM, Simões PS, Lima R de O, Galdino PN, Sousa P de A, et al. Prevalence of metabolic syndrome according to NCEP-ATP III and IDF criteria in patients on hemodialysis. J Bras Nefrol 2015: 37(1):72-8. doi: 10.5935/0101-2800.20150011.
XV. Reddy SM, Anandarajah AP, Fisher MC, Mease PJ, Greenberg JD, Kremer JM, et al. Comparative analysis of disease activity measures, use of biologic agents, body mass index, radiographic features, and bone density in psoriatic arthritis and rheumatoid arthritis patients followed in a large U.S. disease registry. J Rheumatol 2010; 37(12):2566-72. doi: 10.3899/jrheum.100483.
XVI. Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses’ Health Study II. Arch Intern Med 2007; 167:1670-5. doi: 10.1001/archinte.167.15.1670.
XVII. Li B, Huang H, Zhao J, Deng X, Zhang Z. Discrepancy in metabolic syndrome between psoriatic arthritis and rheumatoid arthritis: a direct comparison of two cohorts in one center. Rheumatol Ther 2022 Oct 20. doi: 10.1007/s40744-022-00502-4.
XVIII. de Menezes Ettinger JE, Azaro E, de Souza CA, dos Santos Filho PV, Mello CA, Neves M Jr, et al. Remission of psoriasis after open gastric bypass. Obes Surg 2006; 16:94-7. doi: 10.1381/096089206775221998.
XIX. Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, et al. Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Ann Rheum Dis 2017;76 (11): 1906-1910. doi: 10.1136/annrheumdis-2017-211284.
XX. Fragoulis GE, Evangelatos G, Tentolouris N, Fragkiadaki K, Panopoulos S, Konstantonis G, et al Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus. Ther Adv Musculoskelet Dis 2020;12:1759720X20976975. doi: 10.1177/1759720X20976975.
XXI. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 2004;113(9):1271-6. doi: 10.1172/JCI20945.
XXII. Sokoll KB, Helliwell PS. Comparison of disability and quality of life in rheumatoid and psoriatic arthritis. J Rheumatol 2001;28(8):1842-6. PMID: 11508587.
XXIII. Gregoire ARF, DeRuyter BK, Stratman EJ. Psoriasis flares following systemic glucocorticoid exposure in patients with a history of psoriasis. JAMA Dermatol 2021; 157(2):198-201. doi: 10.1001/jamadermatol.2020.4219.
Copyright (c) 2024 on behalf of the authors. Reproduction rights: Argentine Society of Rheumatology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
